References
- Allen, H. H., (1974). Clinical assessment of a low-dose oestrogen, low-dose progestogen combined oral contraceptive. Curr. med. Res. Opin, 2, 101.1. Allen, H. H., (1974). Clinical assessment of a low-dose oestrogen, low-dose progestogen combined oral contraceptive. Curr. med. Res. Opin, 2, 101.
- Bye, P. g. T., and Elstein, M., (1973). Clinical assessment of a low-oestrogen combined oral contraceptive. Brit. med. J., 2, 389.2. Bye, P. g. T., and Elstein, M., (1973). Clinical assessment of a low-oestrogen combined oral contraceptive. Brit. med. J., 2, 389.
- Doll, R., and Vessey, M. P., (1970). Evaluation of rare adverse effects of systemic contraceptives. Brit. Med. Bull., 26, 33.3. Doll, R., and Vessey, M. P., (1970). Evaluation of rare adverse effects of systemic contraceptives. Brit. Med. Bull., 26, 33.
- Foss, G. L., and Fotherby, K., (1973). Low-oestrogen combined oral contraceptive. Acta Europ. Fertilitatis, 4, 57.4. Foss, g. L., and Fotherby, K., (1973). Low-oestrogen combined oral contraceptive. Acta Europ. Fertilitatis, 4, 57.
- Goldzieher, J. W., Moses, L. E., Averkin, E., Scheel, C., and Taber, B. Z., (1971). A placebo-controlled double-blind crossover investigation of the side effects attributed to oral contraceptives. Fertil. Steril., 22, 609.5. Goldzieher, J. W., Moses, L. E., Averkin, E., Scheel, C., and Taber, B. Z., (1971). A placebo-controlled double-blind crossover investigation of the side effects attributed to oral contraceptives. Fertil. Steril., 22, 609.
- Goldzieher, J. W., Moses, L. E., Averkin, E., Scheel, C., and Taber, B. Z., (1971). Nervousness and depression attributed to oral contraceptives: a double-blind placebo-controlled study. Amer. J. Obstet. Gynecol., 111, 1013.6. Goldzieher, J. W., Moses, L. E., Averkin, E., Scheel, C., and Taber, B. Z., (1971). Nervousness and depression attributed to oral contraceptives: a double-blind placebo-controlled study. Amer. J. Obstet. Gynecol., 111, 1013.
- Inman, W. H. W., Vessey, M. P., Westerholm, B., and Engelund, A., (1970). Thromboembolic disease and the steroidal content of oral contraceptives. Brit. med. J., 2, 203.7. Inman, W. H. W., Vessey, M. P., Westerholm, B., and Engelund, A., (1970). Thromboembolic disease and the steroidal content of oral contraceptives. Brit. med. J., 2, 203.
- Laurie, R. E., and Lewis, E. T., (1968). Fertility control with Ovral. A clinical review. J. Reprod. Pert. Suppl., 5, 95.8. Laurie, R. E., and Lewis, E. T., (1968). Fertility control with Ovral. A clinical review. J. Reprod. Pert. Suppl., 5, 95.
- Preston, S. N., (1972). A report of a collaborative dose-response clinical study using decreasing doses combination oral contraceptives. Contraception, 6, 17.9. Preston, S. N., (1972). A report of a collaborative dose-response clinical study using decreasing doses combination oral contraceptives. Contraception, 6, 17.
- Woutersz, T. B., (1974). A new low-oestrogen, low-progestogen combined oral contraceptive. Curr. med. Res. Opin., 2, 95.10. Woutersz, T. B., (1974). A new low-oestrogen, low-progestogen combined oral contraceptive. Curr. med. Res. Opin., 2, 95.